Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy



Li, Hong, Liu, Tingli, Yang, Yongchun, Cho, William C, Flynn, Robin J ORCID: 0000-0001-5304-3088, Harandi, Majid Fasihi, Song, Houhui, Luo, Xuenong and Zheng, Yadong
(2023) Interplays of liver fibrosis-associated microRNAs: Molecular mechanisms and implications in diagnosis and therapy. GENES & DISEASES, 10 (4). pp. 1457-1469.

Access the full-text of this item by clicking on the Open Access link.

Abstract

microRNAs (miRNAs) are a class of non-coding functional small RNA composed of 21-23 nucleotides, having multiple associations with liver fibrosis. Fibrosis-associated miRNAs are roughly classified into pro-fibrosis or anti-fibrosis types. The former is capable of activating hepatic stellate cells (HSCs) by modulating pro-fibrotic signaling pathways, mainly including TGF-β/SMAD, WNT/β-catenin, and Hedgehog; the latter is responsible for maintenance of the quiescent phenotype of normal HSCs, phenotypic reversion of activated HSCs (aHSCs), inhibition of HSCs proliferation and suppression of the extracellular matrix-associated gene expression. Moreover, several miRNAs are involved in regulation of liver fibrosis via alternative mechanisms, such as interacting between hepatocytes and other liver cells via exosomes and increasing autophagy of aHSCs. Thus, understanding the role of these miRNAs may provide new avenues for the development of novel interventions against hepatic fibrosis.

Item Type: Article
Uncontrolled Keywords: Diagnosis, Hepatic stellate cell, Liver fibrosis, miRNA, Therapy
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Infection, Veterinary and Ecological Sciences
Depositing User: Symplectic Admin
Date Deposited: 25 Jan 2023 12:45
Last Modified: 18 Oct 2023 17:07
DOI: 10.1016/j.gendis.2022.08.013
Open Access URL: https://doi.org/10.1016/j.gendis.2022.08.013
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3167883